Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides

Experimental Cell Research

Volumn 301, Issue 2, 2004, Pages 189-200

  Li, Guang Zhi ^a   Eller, Mark S ^a   Hanna, Kendra ^a   Gilchrest, Barbara A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; DNA damage; p53; pRb

Indexed keywords

ANTINEOPLASTIC AGENT; DNA; OLIGONUCLEOTIDE; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL DAMAGE; CONTROLLED STUDY; DNA DAMAGE; EXPOSURE; FIBROBLAST CULTURE; GENOME; HUMAN; HUMAN CELL; HYPOTHESIS; NEWBORN; PRIORITY JOURNAL; PROTEIN FUNCTION; SENESCENCE; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TANDEM REPEAT; TELOMERE;

EID: 8644238845     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2004.08.019     Document Type: Article

References (97)

1. L. Hayflick, and P.S. Moorhead The serial cultivation of human diploid cell strains Exp. Cell Res. 25 1961 595 621
2. J. Campisi Cancer and ageing: rival demons? Nat. Rev., Cancer 3 2003 339 349
3. J.R. Smith, and O.M. Pereira-Smith Replicative senescence: implications for in vivo aging and tumor suppression Science 273 1996 63 67
4. J. Campisi Cellular senescence as a tumor-suppressor mechanism Trends Cell Biol. 11 2001 S27 S31
5. C.B. Harley, A.B. Futcher, and C.W. Greider Telomeres shorten during ageing of human fibroblasts Nature 345 1990 458 460
6. J. Lindsey, N.I. McGill, L.A. Lindsey, D.K. Green, and H.J. Cooke In vivo loss of telomeric repeats with age in humans Mutat. Res. 256 1991 45 48
7. M.Z. Levy, R.C. Allsopp, A.B. Futcher, C.W. Greider, and C.B. Harley Telomere end-replication problem and cell aging J. Mol. Biol. 225 1992 951 960
8. J. Karlseder, A. Smogorzewska, and T. de Lange Senescence induced by altered telomere state, not telomere loss Science 295 2002 2446 2449
9. S.J. Robles, and G.R. Adami Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts Oncogene 16 1998 1113 1123
10. M. Serrano, A.W. Lin, M.E. McCurrach, D. Beach, and S.W. Lowe Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a Cell 88 1997 593 602
11. J. Zhu, D. Woods, M. McMahon, and J.M. Bishop Senescence of human fibroblasts induced by oncogenic Raf Genes Dev. 12 1998 2997 3007
12. J. Feng, W.D. Funk, S.S. Wang, S.L. Weinrich, A.A. Avilion, C.P. Chiu, R.R. Adams, E. Chang, R.C. Allsopp, and J. Yu The RNA component of human telomerase Science 269 1995 1236 1241
13. L. Harrington, T. McPhail, V. Mar, W. Zhou, R. Oulton, M.B. Bass, I. Arruda, and M.O. Robinson A mammalian telomerase-associated protein Science 275 1997 973 977
14. A.G. Bodnar, M. Ouellette, M. Frolkis, S.E. Holt, C.P. Chiu, G.B. Morin, C.B. Harley, J.W. Shay, S. Lichtsteiner, and W.E. Wright Extension of life-span by introduction of telomerase into normal human cells Science 279 1998 349 352
15. H. Vaziri, and S. Benchimol Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span Curr. Biol. 8 1998 279 282
16. L.W. Elmore, C.W. Rehder, X. Di, P.A. McChesney, C.K. Jackson-Cook, D.A. Gewirtz, and S.E. Holt Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction J. Biol. Chem. 5 2002 5
17. B.D. Chang, E.V. Broude, M. Dokmanovic, H. Zhu, A. Ruth, Y. Xuan, E.S. Kandel, E. Lausch, K. Christov, and I.B. Roninson A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents Cancer Res. 59 1999 3761 3767
18. J.W. Shay, O.M. Pereira-Smith, and W.E. Wright A role for both RB and p53 in the regulation of human cellular senescence Exp. Cell Res. 196 1991 33 39
19. J.G. Rheinwald, W.C. Hahn, M.R. Ramsey, J.Y. Wu, Z. Guo, H. Tsao, M. De Luca, C. Catricala, and K.M. O'Toole A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status Mol. Cell. Biol. 22 2002 5157 5172
20. C.C. Harris, and M. Hollstein Clinical implications of the p53 tumor-suppressor gene N. Engl. J. Med. 329 1993 1318 1327
21. F.Z. Bischoff, S.O. Yim, S. Pathak, G. Grant, M.J. Siciliano, B.C. Giovanella, L.C. Strong, and M.A. Tainsky Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalization Cancer Res. 50 1990 7979 7984
22. J.A. Bond, F.S. Wyllie, and D. Wynford-Thomas Escape from senescence in human diploid fibroblasts induced directly by mutant p53 Oncogene 9 1994 1885 1889
23. L.S. Gollahon, and J.W. Shay Immortalization of human mammary epithelial cells transfected with mutant p53 (273his) Oncogene 12 1996 715 725
24. M.M. Sugrue, D.Y. Shin, S.W. Lee, and S.A. Aaronson Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53 Proc. Natl. Acad. Sci. U. S. A. 94 1997 9648 9653
25. G.H. Stein, M. Beeson, and L. Gordon Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts Science 249 1990 666 669
26. R.A. Weinberg The retinoblastoma protein and cell cycle control Cell 81 1995 323 330
27. H.J. Xu, Y. Zhou, W. Ji, G.S. Perng, R. Kruzelock, C.T. Kong, R.C. Bast, G.B. Mills, J. Li, and S.X. Hu Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition Oncogene 15 1997 2589 2596
28. K. Alexander, and P.W. Hinds Requirement for p27(KIP1) in retinoblastoma protein-mediated senescence Mol. Cell. Biol. 21 2001 3616 3631
29. H. zur Hausen Cervical carcinoma and human papillomavirus: on the road to preventing a major human cancer J. Natl. Cancer Inst. 93 2001 252 253
30. E.C. Goodwin, E. Yang, C.J. Lee, H.W. Lee, D. DiMaio, and E.S. Hwang Rapid induction of senescence in human cervical carcinoma cells Proc. Natl. Acad. Sci. U. S. A. 97 2000 10978 10983
31. S.I. Wells, B.J. Aronow, T.M. Wise, S.S. Williams, J.A. Couget, and P.M. Howley Transcriptome signature of irreversible senescence in human papillomavirus-positive cervical cancer cells Proc. Natl. Acad. Sci. U. S. A. 19 2003 19
32. C.J. Sherr, and F. McCormick The RB and p53 pathways in cancer Cancer Cells 2 2002 103 112
33. W.E. Wright, O.M. Pereira-Smith, and J.W. Shay Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts Mol. Cell. Biol. 9 1989 3088 3092
34. W.C. Hahn, C.M. Counter, A.S. Lundberg, R.L. Beijersbergen, M.W. Brooks, and R.A. Weinberg Creation of human tumour cells with defined genetic elements Nature 400 1999 464 468
35. C.W. Greider Telomere length regulation Annu. Rev. Biochem. 65 1996 337 365
36. V.L. Makarov, Y. Hirose, and J.P. Langmore Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening Cell 88 1997 657 666
37. K.E. Huffman, S.D. Levene, V.M. Tesmer, J.W. Shay, and W.E. Wright Telomere shortening is proportional to the size of the G-rich telomeric 3′-overhang J. Biol. Chem. 275 2000 19719 19722
38. G. Cimino-Reale, E. Pascale, E. Battiloro, G. Starace, R. Verna, and E. D'Ambrosio The length of telomeric G-rich strand 3′-overhang measured by oligonucleotide ligation assay Nucleic Acids Res. 29 2001 E35
39. S.A. Stewart, I. Ben-Porath, V.J. Carey, B.F. O'Connor, W.C. Hahn, and R.A. Weinberg Erosion of the telomeric single-strand overhang at replicative senescence Nat. Genet. 33 2003 492 496
40. R. McElligott, and R.J. Wellinger The terminal DNA structure of mammalian chromosomes EMBO J. 16 1997 3705 3714
41. W.E. Wright, V.M. Tesmer, K.E. Huffman, S.D. Levene, and J.W. Shay Normal human chromosomes have long G-rich telomeric overhangs at one end Genes Dev. 11 1997 2801 2809
42. B. van Steensel, A. Smogorzewska, and T. de Lange TRF2 protects human telomeres from end-to-end fusions Cell 92 1998 401 413
43. J. Karlseder, D. Broccoli, Y. Dai, S. Hardy, and T. de Lange p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2 Science 283 1999 1321 1325
44. A. Smogorzewska, and T. De Lange Different telomere damage signaling pathways in human and mouse cells EMBO J. 21 2002 4338 4348
45. I.M. Hadshiew, M.S. Eller, F.P. Gasparro, and B.A. Gilchrest Stimulation of melanogenesis by DNA oligonucleotides: effect of size, sequence and 5′ phosphorylation J. Dermatol. Sci. 25 2001 127 138
46. G.Z. Li, M.S. Eller, R. Firoozabadi, and B.A. Gilchrest Evidence that exposure of the telomere 3′ overhang sequence induces senescence Proc. Natl. Acad. Sci. U. S. A. 100 2003 527 531
47. M.S. Eller, N. Puri, I.M. Hadshiew, S.S. Venna, and B.A. Gilchrest Induction of apoptosis by telomere 3′ overhang-specific DNA Exp. Cell Res. 276 2002 185 193
48. N.E.M.S. Puri, H.R. Byers, S. Dykstra, J. Kubera, and B.A. Gilchrest Telomere-based DNA damage responses: a new approach to melanoma FASEB J. 18 2004 1373 1381
49. M.S. Eller, G.Z. Li, R. Firoozabadi, N. Puri, and B.A. Gilchrest Induction of a p95/Nbs1-mediated S phase checkpoint by telomere 3′ overhang specific DNA FASEB J. 17 2003 152 162
50. E. Gottlieb, R. Haffner, T. von Ruden, E.F. Wagner, and M. Oren Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal EMBO J. 13 1994 1368 1374
51. E. Shaulian, A. Zauberman, D. Ginsberg, and M. Oren Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding Mol. Cell. Biol. 12 1992 5581 5592
52. G.I. Shapiro, C.D. Edwards, M.E. Ewen, and B.J. Rollins p16INK4A participates in a G1 arrest checkpoint in response to DNA damage Mol. Cell. Biol. 18 1998 378 387
53. T. Wolfel, M. Hauer, J. Schneider, M. Serrano, C. Wolfel, E. Klehmann-Hieb, E. De Plaen, T. Hankeln, K.H. Meyer zum Buschenfelde, and D. Beach A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma Science 269 1995 1281 1284
54. G.P. Dimri, X. Lee, G. Basile, M. Acosta, G. Scott, C. Roskelley, E.E. Medrano, M. Linskens, I. Rubelj, O. Pereira-Smith, and J. Campisi A biomarker that identifies senescent human cells in culture and in aging skin in vivo Proc. Natl. Acad. Sci. U. S. A. 92 1995 9363 9367
55. M.S. Eller, K. Ostrom, and B.A. Gilchrest DNA damage enhances melanogenesis Proc. Natl. Acad. Sci. U. S. A. 93 1996 1087 1092
56. E. Shaulian, A. Zauberman, D. Ginsberg, and M. Oren Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding Mol. Cell. Biol. 12 1992 5581 5592
57. S.G. Rane, S.C. Cosenza, R.V. Mettus, and E.P. Reddy Germ line transmission of the Cdk4(R24C) mutation facilitates tumorigenesis and escape from cellular senescence Mol. Cell. Biol. 22 2002 644 656
58. X. Zou, D. Ray, A. Aziyu, K. Christov, A.D. Boiko, A.V. Gudkov, and H. Kiyokawa Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence Genes Dev. 16 2002 2923 2934
59. F.Y. Luh, S.J. Archer, P.J. Domaille, B.O. Smith, D. Owen, D.H. Brotherton, A.R. Raine, X. Xu, L. Brizuela, S.L. Brenner, and E.D. Laue Structure of the cyclin-dependent kinase inhibitor p19Ink4d Nature 389 1997 999 1003
60. I.J. Byeon, J. Li, K. Ericson, T.L. Selby, A. Tevelev, H.J. Kim, P. O'Maille, and M.D. Tsai Tumor suppressor p16INK4A: determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4 Mol. Cell 1 1998 421 431
61. J. Li, I.J. Byeon, K. Ericson, M.J. Poi, P. O'Maille, T. Selby, and M.D. Tsai Tumor suppressor INK4: determination of the solution structure of p18INK4C and demonstration of the functional significance of loops in p18INK4C and p16INK4A Biochemistry 38 1999 2930 2940
62. C. Yuan, T.L. Selby, J. Li, I.J. Byeon, and M.D. Tsai Tumor suppressor INK4: refinement of p16INK4A structure and determination of p15INK4B structure by comparative modeling and NMR data Protein Sci. 9 2000 1120 1128
63. T. Wolfel, M. Hauer, J. Schneider, M. Serrano, C. Wolfel, E. Klehmann-Hieb, E. De Plaen, T. Hankeln, K.H. Meyer zum Buschenfelde, and D. Beach A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma Science 269 1995 1281 1284
64. B.D. Chang, K. Watanabe, E.V. Broude, J. Fang, J.C. Poole, T.V. Kalinichenko, and I.B. Roninson Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases Proc. Natl. Acad. Sci. U. S. A. 97 2000 4291 4296
65. K. Damm, U. Hemmann, P. Garin-Chesa, N. Hauel, I. Kauffmann, H. Priepke, C. Niestroj, C. Daiber, B. Enenkel, B. Guilliard, I. Lauritsch, E. Muller, E. Pascolo, G. Sauter, M. Pantic, U.M. Martens, C. Wenz, J. Lingner, N. Kraut, W.J. Rettig, and A. Schnapp A highly selective telomerase inhibitor limiting human cancer cell proliferation EMBO J. 20 2001 6958 6968
66. P.W. Hinds, S. Mittnacht, V. Dulic, A. Arnold, S.I. Reed, and R.A. Weinberg Regulation of retinoblastoma protein functions by ectopic expression of human cyclins Cell 70 1992 993 1006
67. C.J. Sherr Cancer cell cycles Science 274 1996 1672 1677
68. L. Connell-Crowley, J.W. Harper, and D.W. Goodrich Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation Mol. Biol. Cell 8 1997 287 301
69. M. Kitagawa, H. Higashi, H.K. Jung, I. Suzuki-Takahashi, M. Ikeda, K. Tamai, J. Kato, K. Segawa, E. Yoshida, S. Nishimura, and Y. Taya The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2 EMBO J. 15 1996 7060 7069
70. N.W. Kim, M.A. Piatyszek, K.R. Prowse, C.B. Harley, M.D. West, P.L. Ho, G.M. Coviello, W.E. Wright, S.L. Weinrich, and J.W. Shay Specific association of human telomerase activity with immortal cells and cancer Science 266 1994 2011 2015
71. K. Masutomi, E.Y. Yu, S. Khurts, I. Ben-Porath, J.L. Currier, G.B. Metz, M.W. Brooks, S. Kaneko, S. Murakami, J.A. DeCaprio, R.A. Weinberg, S.A. Stewart, and W.C. Hahn Telomerase maintains telomere structure in normal human cells Cell 114 2003 241 253
72. T. vonZglinicki Role of oxidative stress in telomere length regulation and replicative senescence Ann. N. Y. Acad. Sci. 908 2000 99 110
73. Q.M. Chen, J.C. Bartholomew, J. Campisi, M. Acosta, J.D. Reagan, and B.N. Ames Molecular analysis of H2O2-induced senescent-like growth arrest in normal human fibroblasts: p53 and Rb control G1 arrest but not cell replication Biochem. J. 332 1998 43 50
74. J.D. Griffith, L. Comeau, S. Rosenfield, R.M. Stansel, A. Bianchi, H. Moss, and T. de Lange Mammalian telomeres end in a large duplex loop Cell 97 1999 503 514
75. E.H. Blackburn Telomere states and cell fates Nature 408 2000 53 56
76. N.E. Sharpless, and R.A. DePinho Telomeres, stem cells, senescence, and cancer J. Clin. Invest. 113 2004 160 168
77. P. Kahlem, B. Dorken, and C.A. Schmitt Cellular senescence in cancer treatment: friend or foe? J. Clin. Invest. 113 2004 169 174
78. J. Campisi Cellular senescence and apoptosis: how cellular responses might influence aging phenotypes Exp. Gerontol. 38 2003 5 11
79. S.W. Lowe, H.E. Ruley, T. Jacks, and D.E. Housman p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents Cell 74 1993 957 967
80. A. Rebbaa, X. Zheng, P.M. Chou, and B.L. Mirkin Caspase inhibition switches doxorubicin-induced apoptosis to senescence Oncogene 22 2003 2805 2811
81. C.A. Schmitt, J.S. Fridman, M. Yang, S. Lee, E. Baranov, R.M. Hoffman, and S.W. Lowe A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy Cell 109 2002 335 346
82. M. Hollstein, K. Rice, M.S. Greenblatt, T. Soussi, R. Fuchs, T. Sorlie, E. Hovig, B. Smith-Sorensen, R. Montesano, and C.C. Harris Database of p53 gene somatic mutations in human tumors and cell lines Nucleic Acids Res. 22 1994 3551 3555
83. C.A. Schmitt Senescence, apoptosis and therapy-Cutting the lifelines of cancer Nat. Rev., Cancer 3 2003 286 295
84. C.A. Schmitt, C.T. Rosenthal, and S.W. Lowe Genetic analysis of chemoresistance in primary murine lymphomas Nat. Med. 6 2000 1029 1035
85. C.A. Schmitt, J.S. Fridman, M. Yang, E. Baranov, R.M. Hoffman, and S.W. Lowe Dissecting p53 tumor suppressor functions in vivo Cancer Cells 1 2002 289 298
86. C.A. Schmitt, and S.W. Lowe Apoptosis and chemoresistance in transgenic cancer models J. Mol. Med. 80 2002 137 146
87. J.M. Brown, and B.G. Wouters Apoptosis, p53, and tumor cell sensitivity to anticancer agents Cancer Res. 59 1999 1391 1399
88. M. Yaar, I. Panova, C. Rinaldi, M.S. Eller, and B.A. Gilchrest A novel therapy for tumors of epithelial origin J. Invest. Dermatol. 112 2004 A43 (Abstract #255)
89. S. Agrawal, J. Temsamani, W. Galbraith, and J. Tang Pharmacokinetics of antisense oligonucleotides Clin. Pharmacokinet. 28 1995 7 16
90. W.E. Wright, D. Brasiskyte, M.A. Piatyszek, and J.W. Shay Experimental elongation of telomeres extends the lifespan of immortal × normal cell hybrids EMBO J. 15 1996 1734 1741
91. J.W. Shay, and W.E. Wright Telomerase: a target for cancer therapeutics Cancer Cells 2 2002 257 265
92. E.S. Wang, K. Wu, A.C. Chin, S. Chen-Kiang, K. Pongracz, S. Gryaznov, and M.A. Moore Telomerase inhibition with an oligonucleotide telomerase template antagonist: in vitro and in vivo studies in multiple myeloma and lymphoma Blood 103 2004 258 266
93. D.R. Corey Telomerase inhibition, oligonucleotides, and clinical trials Oncogene 21 2002 631 637
94. G. Saretzki, N. Sitte, U. Merkel, R.E. Wurm, and T. vonZglinicki Telomere shortening triggers a p53-dependent cell cycle arrest via accumulation of G-rich single stranded DNA fragments Oncogene 18 1999 5148 5158
95. M.S. Eller, M. Yaar, and B.A. Gilchrest DNA damage and melanogenesis Nature 372 1994 413 414
96. M.S. Eller, T. Maeda, C. Magnoni, D. Atwal, and B.A. Gilchrest Enhancement of DNA repair in human skin cells by thymidine dinucleotides: evidence for a p53-mediated mammalian SOS response Proc. Natl. Acad. Sci. U. S. A. 94 1997 12627 12632
97. D.A. Goukassian, S. Bagheri, L. el-Keeb, M.S. Eller, and B.A. Gilchrest DNA oligonucleotide treatment corrects the age-associated decline in DNA repair capacity FASEB J. 16 2002 754 756